PrimeVigilance, an Ergomed Group company, was established in 2008 by Dr. Miroslav Reljanovic together with co-founder Dr. Elliot Brown. PrimeVigilance oﬀers holistic, top quality, cost-eﬀective, innovative safety services for pharmaceutical, generic and biotechnology companies. Our founders and leaders have an unrivalled reputation in the sector with a network of expert associates across the world. These include former senior regulators and consultants with extensive industry experience, especially with marketed products.
PrimeVigilance has grown organically since 2008 and we now have over 800 people working from our seven main offices in the United Kingdom, United States, Croatia, Czech Republic, Germany, Poland, Serbia and Japan. Our pharmacovigilance services cover all the regulatory and scientific elements required to obtain and maintain a product licence. PrimeVigilance also offers fully integrated international Medical Information, Pharmacoepidemiology and Benefit-Risk Management services. PrimeVigilance specialises in helping emerging companies comply with regulations, from developing the initial Detailed Description of PV Systems and RMP right through to full management of safety operations.
PrimeVigilance is a subsidiary of Ergomed plc. and is managed by its own Board of Directors which includes leading pharmacovigilance experts
PrimeVigilance recognises that its activities and operations have a societal impact and we place a high emphasis on our social responsibilities.
“It has been a pleasure working with you, having your expertise and prompt support with our literature search activities – all much-much appreciated!”
Large worldwide Pharmaceutical company
“I’ve been most impressed by your quarterly safety detection methods and would like to incorporate them for other studies I am responsible for.”
“I wanted to write to you to let you know of the excellent help and support we received prior to and during the Inspection by members of the PrimeVigilance team.”
Swiss Pharmaceutical Company
“We sincerely thank you all for your help and successful labor during this year and we are looking forward to work with you as well in the future.”
Global Drug Safety Section
“Knowing I have you as partners helps me sleep soundly at night.”
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)